Online citations, reference lists, and bibliographies.

Targeted Delivery Of Low Molecular Drugs Using Chitosan And Its Derivatives.

Jae Hyung Park, Gurusamy Saravanakumar, Kwangmeyung Kim, Ick Chan Kwon
Published 2010 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Chitosan has prompted the continuous impetus for the development of safe and effective drug delivery systems because of its unique physicochemical and biological characteristics. The primary hydroxyl and amine groups located on the backbone of chitosan allow for chemical modification to control its physical properties. When the hydrophobic moiety is conjugated to a chitosan molecule, the resulting amphiphile may form self-assembled nanoparticles that can encapsulate a quantity of drugs and deliver them to a specific site of action. Chemical attachment of the drug to the chitosan throughout the functional linker may produce useful prodrugs, exhibiting the appropriate biological activity at the target site. Mucoadhesive and absorption enhancement properties of chitosan increase the in vivo residence time of the dosage form in the gastrointestinal tract and improve the bioavailability of various drugs. The main objective of this review is to provide an insight into various target-specific carriers, based on chitosan and its derivatives, towards low molecular weight drug delivery. The first part of the review is concerned with the organ-specific delivery of low molecular drugs using chitosan and its derivatives. The subsequent section considers the recent developments of drug delivery carriers for cancer therapy with special focus on various targeting strategies.
This paper references
10.1021/bm0608176
Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers.
Yong Hu (2007)
Drug delivery and targeting.
Robert S Langer (1998)
Effects of nonsteroidal antiin fl ammatory drugs on proteinuria
A. J. Donker R. Vriesendorp (1986)
N - acetyl histidineconjugated glycol chitosan self - assembled nanoparticles for intracytoplasmic delivery of drugs : endocytosis , exocytosis and drug release
S. Mardyani H. Zhang (2006)
10.3109/10611869308998759
Targeting anticancer drugs to the brain. I: Enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres.
Emad Eldin Hassan (1993)
10.1016/j.jconrel.2007.05.037
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
Sergio Cafaggi (2007)
10.1021/bm050912z
Design of biocompatible chitosan microgels for targeted pH-mediated intracellular release of cancer therapeutics.
Hong Zhang (2006)
10.1016/J.COLSURFB.2007.07.012
Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro.
Xindu Yang (2008)
10.1007/S00396-009-2022-3
Self-assembling chitosan/poly-γ-glutamic acid nanoparticles for targeted drug delivery
Zsolt Keresztessy (2009)
10.1016/j.jconrel.2005.11.014
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Maryam Amidi (2006)
10.1023/A:1015987516796
A Novel Approach to the Oral Delivery of Micro- or Nanoparticles
Roland Bodmeier (2004)
Novel super pHsensitive nanoparticles responsive to tumor extracellular pH , Carbohyd
J. S. Park (2008)
Release behavior of 5fl uorouracil from chitosangel nanospheres immobilizing 5fl uorouracil coated with polysaccharides and their cell speci fi c cytotoxicity , Pure Appl
Y. Ohya (2005)
Effect of molecular weight and ionic strength on the formation of polyelectrolyte complexes based on poly(methacrylic acid) and chitosan, Biomacromolecules
C. L. de Vasconcelos (2006)
10.1016/j.ijpharm.2007.05.028
Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
Kristina Mladenovska (2007)
10.1016/j.jconrel.2004.08.010
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
Sunil A. Agnihotri (2004)
10.1080/10611860600833880
Polymer conjugates for drug targeting. From inspired to inspiration!
Ruth Duncan (2006)
10.1021/cr030441b
Chitosan chemistry and pharmaceutical perspectives.
Majeti N V Ravi Kumar (2004)
10.1016/S0168-3659(01)00294-2
Chitosan nanoparticles as delivery systems for doxorubicin.
Kenneth A. Janes (2001)
10.1016/S0142-9612(02)00071-6
Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles.
Yong Hu (2002)
10.1016/S0168-3659(02)00084-6
Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
Hideyuki Tozaki (2002)
10.1007/s003960000389
Self-aggregates of deoxycholic acid-modified chitosan as a novel carrier of adriamycin
Kuen Yong Lee (2000)
10.1016/S0169-409X(02)00226-0
PEGylated nanoparticles for biological and pharmaceutical applications
Hidenori Otsuka (2003)
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Quentin A Pankhurst (2003)
10.1016/S0167-6296(02)00126-1
The price of innovation: new estimates of drug development costs.
Joseph A DiMasi (2003)
10.1016/j.chembiol.2004.12.007
Targeting cancer cells with dendrimers.
Srinivasa-Gopalan Sampathkumar (2005)
10.1016/S0168-3659(03)00231-1
Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect.
Yoen Ju Son (2003)
10.1038/ki.1997.504
Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo.
Marijke Haas (1997)
10.1021/bm0502258
Preparation and characterization of chitosan-based nanoparticles.
Magdolna Bodnár (2005)
10.1080/02652040600612405
Colon-specific delivery of mesalazine chitosan microspheres
Jaleh Varshosaz (2006)
10.1021/la0350608
Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic Acid
Seunglee Kwon (2003)
10.1016/j.jconrel.2008.05.003
Recent progress in tumor pH targeting nanotechnology.
Eun Seong Lee (2008)
10.1016/j.addr.2008.09.001
Polysaccharides-based nanoparticles as drug delivery systems.
Zonghua Liu (2008)
10.1021/bm0605053
Synthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticles.
Magdolna Bodnár (2006)
10.1021/bc9801124
Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
Alberto Gabizon (1999)
10.1016/j.biomaterials.2003.10.097
The targeting of anionized polyvinylpyrrolidone to the renal system.
Hiroshi Kodaira (2004)
10.1016/j.ejpb.2006.06.001
Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system.
Praneet Opanasopit (2006)
10.1088/0957-4484/19/25/255103
Improved cytotoxicity of doxorubicin by enhancing its nuclear delivery mediated via nanosized micelles.
Jian You (2008)
10.2307/j.ctvrnfqk1.10
? ? ? ? f ? ? ? ? ?
A ADoefaa (2003)
10.1002/jps.20520
Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin.
Shirui Mao (2006)
10.1163/156856207779996931
Nanostructured materials for applications in drug delivery and tissue engineering
Michael S Goldberg (2007)
Pulmonary fi brosis produced in F344 rats by subchronic inhalation of aerosols of a 4000 molecular weight ethylene oxide / propylene oxide polymer , Fundam
D. E. Dodd D. R. Klonne (2007)
10.1016/j.jconrel.2008.01.013
Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Kyung Hyun Min (2008)
10.1016/J.IJPHARM.2007.10.035
Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
Yi-qing Ye (2008)
10.1007/978-0-387-85600-1_20
Applications of Magnetic Nanoparticles in Biomedicine
C. Bárcena (2003)
10.1016/S0065-2571(00)00013-3
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.
Hirofumi Maeda (2001)
Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery
정서영 (2005)
10.1002/jps.20586
Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan.
Young-Il Jeong (2006)
10.1016/S0168-3659(01)00342-X
Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier.
Santosh Mitra (2001)
10.1016/j.ijpharm.2004.12.017
Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
Gihan Fetih (2005)
10.1016/j.jconrel.2006.07.011
N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
Ji sun Park (2006)
10.2174/1573413052953110
Nanosystems in Drug Targeting: Opportunities and Challenges
Jaspreet K. Vasir (2005)
10.1016/S1773-2247(08)50062-1
Targeted delivery of 5-ASA to colon using chitosan hydrogel microspheres
Sanjay Kumar Jain (2008)
10.1088/0957-4484/19/18/185101
Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan.
Adriana Trapani (2008)
10.1016/j.biomaterials.2004.07.038
An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes.
Wenguang Liu (2005)
10.1186/bcr329
Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment
Helen C. Hurst (2001)
10.1021/bm049305m
Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates.
Kwangmeyung Kim (2005)
10.1021/jm800767c
Conjugated chitosan as a novel platform for oral delivery of paclitaxel.
Eunhye Lee (2008)
10.1038/nrd1033
Effect of pegylation on pharmaceuticals
Joanna M. Harris (2003)
10.1016/j.biomaterials.2006.12.031
New acrylic microspheres for arterial embolization: combining radiopacity for precise localization with immobilized thrombin to trigger local blood coagulation.
Ketie Saralidze (2007)
10.1016/0272-0590(88)90195-9
Pulmonary fibrosis produced in F-344 rats by subchronic inhalation of aerosols of a 4000 molecular weight ethylene oxide/propylene oxide polymer.
Dennis R. Klonne (1988)
Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5fl uorouracil , Carbohyd
A. Gabizon (2008)
10.1016/j.addr.2008.08.005
Active targeting schemes for nanoparticle systems in cancer therapeutics.
James D. Byrne (2008)
10.1016/S0939-6411(03)00061-4
Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins.
V. Leitner (2003)
10.1038/nrc2394
Paul Ehrlich's magic bullet concept: 100 years of progress
Klaus Strebhardt (2008)
10.1016/S0144-8617(03)00090-0
Preparation of N-alkyl-O-sulfate chitosan derivatives and micellar solubilization of taxol
Can Zhang (2003)
10.1166/jbn.2005.021
Conjugation of Monodisperse Chitosan-Bound Magnetic Nanocarrier with Epirubicin for Targeted Cancer Therapy
Yang-chuang Chang (2005)
Chess , Effect of pegylation on pharmaceuticals
R. B. J. M. Harris (2003)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
10.1021/bm050963w
Effect of molecular weight and ionic strength on the formation of polyelectrolyte complexes based on poly(methacrylic acid) and chitosan.
Carla Maria Lins de Vasconcelos (2006)
10.1016/j.ejps.2008.08.008
In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors.
Anekant Jain (2008)
10.1021/mp800078a
Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan.
Zhi-Xiang Yuan (2009)
Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: conjugation, targeting, and biodistribution.
Eun-Mi Kim (2005)
10.1515/9783111413426-013
L
Il Liceo (1824)
Chitosan - modi fi cations and applications : opportunities galore , React
N. N. Inamdar V. K. Mourya (2006)
10.1517/17425247.5.5.483
Target-specific drug release to the colon.
Sanjay K Jain (2008)
10.2745/dds.11.119
Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon.
Hideyuki Tozaki (1996)
10.1016/J.EJPB.2007.04.007
Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-fluorouracil delivery.
Yongli Zheng (2007)
10.1016/J.EJPB.2007.06.016
Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system.
Tomoko Oosegi (2008)
10.1016/j.ejps.2007.01.002
N-phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles.
Praneet Opanasopit (2007)
10.1023/A:1011929016601
Chitosan and Its Use as a Pharmaceutical Excipient
Lisbeth Ilium (1998)
10.1007/s10438-005-0002-z
Chitosan-based polyelectrolyte complexes: A review
A. V. Il’ina (2005)
Antitumor ef fi cacy of cisplatinloaded glycol chitosan nanoparticles in tumorbearing mice
Y. S. Kim (2004)
10.1002/jps.21487
Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.
Rui Yang (2009)
10.1016/0002-9343(86)90910-1
Effects of nonsteroidal anti-inflammatory drugs on proteinuria.
R. D. Vriesendorp (1986)
10.1080/10601329409349743
Release Behavior of 5-Fluorouracil from Chitosan-Gel Nanospheres Immobilizing 5-Fluorouracil Coated with Polysaccharides and Their Cell Specific Cytotoxicity
Yuichi Ohya (1994)
10.1007/s10126-005-0097-5
Chitin and Chitosan: Functional Biopolymers from Marine Crustaceans
Keisuke Kurita (2005)
Long-circulating and target-specific nanoparticles: theory to practice.
Seyed Moein Moghimi (2001)
10.1016/j.colsurfb.2004.09.002
Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system.
Can Yang Zhang (2004)
10.1016/j.colsurfb.2008.07.020
Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies.
Longzhang Zhu (2009)
10.1016/J.EJPB.2007.09.018
Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
Fu-qiang Hu (2008)
10.1016/J.CARBPOL.2007.12.006
Novel super pH-sensitive nanoparticles responsive to tumor extracellular pH
Li Fan (2008)
10.1016/J.CARBPOL.2007.09.004
Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5-fluorouracil
Can Bang Zhang (2008)
10.1016/j.ejps.2008.01.012
Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs.
Can Yang Zhang (2008)
10.1016/j.ijpharm.2008.03.039
Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Aihua Lin (2008)
10.1088/0957-4484/19/14/145101
Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel.
Yin-Song Wang (2008)
10.1080/10611860701289875
Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier
Zhi-Xiang Yuan (2007)
10.1080/10717540802605376
DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin
Xiaoyun Cheng (2009)
10.1021/bm034094r
Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability.
Jae Hyung Park (2003)
10.1023/B:PHAM.0000012156.65125.01
Anticancer Drug Delivery with Transferrin Targeted Polymeric Chitosan Vesicles
Christine Dufès (2004)
10.1038/265407a0
Targeting of drugs
Gregory Gregoriadis (1977)
10.1016/j.colsurfb.2009.07.027
Incorporation methods for cholic acid chitosan-g-mPEG self-assembly micellar system containing camptothecin.
Tanasait Ngawhirunpat (2009)
Renal drug targeting using a vector "alkylglycoside".
Kokichi Suzuki (1999)
10.1615/CritRevTherDrugCarrierSyst.v19.i45.40
Pulmonary drug delivery systems: recent developments and prospects.
Hélène M. Courrier (2002)
10.1016/j.ejpb.2008.01.016
Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin.
Wei Sun (2008)
10.1200/JCO.1999.17.2.478
Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer.
Anthony W. Tolcher (1999)
10.1021/bm801225m
Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Ziming Zhao (2009)
Acid pH in tumors and its potential for therapeutic exploitation.
Ian F. Tannock (1989)
10.1038/nbt1283-869
Site–Specific (Targeted) Drug Delivery in Cancer Therapy
George Poste (1983)
Preparation of NalkylOsulfate chitosan derivatives and micellar solubilization of taxol , Carbohyd
Q. Ping C. Zhang (2003)
10.1016/j.jconrel.2003.10.005
Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
Andreas Bernkop-Schnürch (2004)
10.1002/jbm.a.31866
Novel polyion complex micelles for liver-targeted delivery of diammonium glycyrrhizinate: in vitro and in vivo characterization.
Ke Yang (2009)
10.3109/03639049809089942
Chitosan: a unique polysaccharide for drug delivery.
O. Felt (1998)
10.1038/nrd2199
How many drug targets are there?
John P. Overington (2006)
10.1016/j.ejps.2009.01.004
PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation.
Guowei Qu (2009)
Knetsch, New acrylic microspheres for arterial embolization: combining radiopacity for precise localization with immobilized thrombin to trigger local blood coagulation, Biomaterials
K. Saralidze (2007)
10.1016/J.REACTFUNCTPOLYM.2008.03.002
Chitosan-modifications and applications: Opportunities galore
Vishnukant Mourya (2008)
10.1021/LA7008545
Polyelectrolyte complexes from polysaccharides: formation and stoichiometry monitoring.
Alexandre Drogoz (2007)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1016/S0168-3659(97)00203-4
Design of microencapsulated chitosan microspheres for colonic drug delivery.
M L Lorenzo-Lamosa (1998)
10.1038/bjc.1991.190
N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.
Leonard W Seymour (1991)
10.1080/10717540490445955
Design and Development of Multiparticulate System for Targeted Drug Delivery to Colon
Manish Kumar Chourasia (2004)
Requirement of the Na+/H+ exchanger for tumor growth.
Daniela Rotin (1989)
10.1016/S0142-9612(03)00598-2
N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
Yoshinori Kato (2004)
10.1007/s00018-004-4153-5
Targeted polymeric micelles for delivery of poorly soluble drugs
Vladimir Torchilin (2004)
10.1016/S0168-3659(03)00126-3
Chitosan-based gastrointestinal delivery systems.
Radi Hejazi (2003)
10.1016/j.jconrel.2005.12.013
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Jong-Ho Kim (2006)
10.1016/j.eurpolymj.2006.09.007
Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin
Yinsong Wang (2007)
10.1002/chin.200226275
Transferrin/transferrin receptor-mediated drug delivery.
Hongyan Li (2002)
10.1016/S0168-3659(99)00015-2
Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution.
Ken-ichi Ogawara (1999)
10.1016/S0142-9612(98)00159-8
Biodegradation and distribution of water-soluble chitosan in mice.
Hayato Onishi (1999)
10.1248/cpb.40.2822
Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin.
Yingwen Song (1992)
10.1016/S0065-2571(98)00018-1
Causes and consequences of acidic pH in tumors: a magnetic resonance study.
Marion Stubbs (1999)
gamma-Glutamyl dopa: a kidney-specific dopamine precursor.
S Wilk (1978)
10.1515/9783111576855-009
D
Saskia Bonjour (1824)
Target - speci fi c drug release to the colon , Expert
A. Jain (2004)
10.1016/j.actbio.2008.02.002
A stimulus-responsive magnetic nanoparticle drug carrier: magnetite encapsulated by chitosan-grafted-copolymer.
Q. Yuan (2008)
10.1038/nrc903
Ligand-targeted therapeutics in anticancer therapy
Theresa M. Allen (2002)
10.1021/bm070365c
Polymeric micelles with glycolipid-like structure and multiple hydrophobic domains for mediating molecular target delivery of paclitaxel.
Jian You (2007)
10.1021/mp050010c
Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery.
Gang-biao Jiang (2006)
10.1126/science.8128245
Biodegradable long-circulating polymeric nanospheres.
Ruxandra Gref (1994)
10.1038/bjc.1996.518
Fluorescence ratio imaging of interstitial pH in solid tumours: effect of glucose on spatial and temporal gradients.
Marc Dellian (1996)
10.1088/0022-3727/36/13/201
Applications of magnetic nanoparticles in biomedicine
Quentin A Pankhurst (2003)
Grif fi ths , Causes and consequences of acidic pH in tumors : a magnetic resonance study
G. Helmlinger M. Dellian (1999)
10.1002/PAT.1195
Preparation and characterization of metronidazole-loaded chitosan nanoparticles for drug delivery application
Ahmed A Elzatahry (2008)
10.1016/J.NANO.2007.08.002
Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Jing Zhang (2007)
10.1016/j.jconrel.2008.02.003
Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
H. Hwang (2008)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Yumi Matsumura (1986)
10.1007/s005950300055
Relationship Between Microvessel Density and Thermographic Hot Areas in Breast Cancer
Toshiro Yahara (2003)
10.1016/S0168-3659(00)00356-4
Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice.
Yoshinori Kato (2001)
10.1208/pt0803056
Design and development of hydrogel beads for targeted drug delivery to the colon
Sanjay K. Jain (2007)
10.1080/10717540490280778
Polysaccharides for Colon Targeted Drug Delivery
Manish Kumar Chourasia (2004)
10.1016/S0142-9612(98)00036-2
Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties.
Anne Denuzière (1998)
10.1002/polc.5070510111
Structure and properties of pharmacologically active polymers
Helmut Prof. Dr. Ringsdorf (2007)
10.1016/j.ijpharm.2008.12.007
Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Rui Yang (2009)
10.1211/0022357021778646
Efficacy of lactosaminated and intact N-succinylchitosan-mitomycin C conjugates against M5076 liver metastatic cancer.
Yoshinori Kato (2002)
10.1038/nrd1088
The dawning era of polymer therapeutics
Ruth Duncan (2003)
10.1088/0957-4484/19/04/045102
Folate-conjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity.
Jian You (2008)
10.1517/17425247.5.9.1003
Antibody-modified liposomes for cancer chemotherapy.
Vladimir Torchilin (2008)
10.1080/10717540590889781
Chitosan-Based Particles as Controlled Drug Delivery Systems
Mani Prabaharan (2005)
10.1007/s11095-007-9480-4
A Biodegradable pH-sensitive Micelle System for Targeting Acidic Solid Tumors
Vijay A. Sethuraman (2007)
10.1088/1748-6041/2/3/S02
Receptor-mediated gene delivery using chemically modified chitosan.
Tae Hee Kim (2007)
10.3322/CA.2007.0010
Cancer statistics, 2008.
Ahmedin Jemal (2008)
10.3748/WJG.14.3554
Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice.
Dan-ying Zhang (2008)
10.1016/j.jconrel.2007.12.014
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Jong-Ho Kim (2008)
10.1016/j.colsurfb.2008.11.026
Self-aggregated nanoparticles from linoleic acid modified carboxymethyl chitosan: Synthesis, characterization and application in vitro.
Yu-long Tan (2009)



This paper is referenced by
10.1016/J.CARBPOL.2011.01.036
Carboxymethyl chitosan prevents formation of broad-spectrum biofilm
Yulong Tan (2011)
10.1007/s13233-012-0022-5
Effect of bond linkage on in vitro drug release and anti-HIV activity of chitosan-stavudine conjugates
Rong Zeng (2012)
10.2174/22117385113019990001
Folic Acid Conjugated Chitosan Nanoparticles for Tumor Targeting of Therapeutic and Imaging Agents
Driton Vllasaliu (2013)
10.2478/s11696-013-0409-6
Comparative study of particle size analysis of hydroxyapatite-based nanomaterials
Réka Barabás (2013)
10.1016/B978-0-12-396983-5.00001-6
Polymer Synthesis and Processing
Mahadevappa Y. Kariduraganavar (2014)
10.1016/j.actbio.2013.10.009
Decanoic acid-modified glycol chitosan hydrogels containing tightly adsorbed palmityl-acylated exendin-4 as a long-acting sustained-release anti-diabetic system.
Changkyu Lee (2014)
10.1016/j.carbpol.2014.03.097
Characterization and cytocompatibility of an antibiotic/chitosan/cyclodextrins nanocoating on titanium implants.
Monica Mattioli-Belmonte (2014)
10.1081/E-EBPP-120052551
Cancer Therapy: Polymeric Nanoparticles
Kwangmeyung Kim (2015)
10.1016/j.ijbiomac.2018.01.006
Chitosan: An undisputed bio-fabrication material for tissue engineering and bio-sensing applications.
Anupriya Baranwal (2018)
Development of hybrid chitosan hydrogels: combined application in magnetic hyperthermia and drug delivery
María Vanessa Zamora Mora (2014)
10.14710/jksa.18.2.62-66
Pengaruh Berat Molekul Kitosan terhadap Efisiensi Enkapsulasi BSA (Bovine Serum Albumin) Menggunakan Agen Crosslink Asam Sitrat
Kimia Sains (2020)
10.1016/j.ijbiomac.2018.11.220
Agarose-chitosan hydrogel-immobilized horseradish peroxidase with sustainable bio-catalytic and dye degradation properties.
Muhammad Bilal (2019)
10.1016/j.carbpol.2018.10.007
Brij-grafted-chitosan copolymers with function of P-glycoprotein modulation: Synthesis, characterization and in vitro investigations.
Wei Xiong (2019)
10.3390/md13116566
Chitosanases from Family 46 of Glycoside Hydrolases: From Proteins to Phenotypes
Pascal Viens (2015)
10.1016/j.ijpharm.2012.04.004
Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid) and tripolyphosphate as protein delivery systems.
Sofia A. Papadimitriou (2012)
10.1039/C5PY02025E
The conjugation of Cu/Zn superoxide dismutase (SOD) to O-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (O-HTCC) enhances its therapeutic potential against radiation-induced oxidative damage
L. Xu (2016)
10.1016/j.jconrel.2011.03.027
Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy.
So Jin Lee (2011)
CHITOSAN-MEDIATED ORAL GENE THERAPY FOR HEMOPHILIA TREATMENT AND PROPHYLACTIC TOLERANCE
Singh Sukhdeep Dhadwar (2011)
10.1016/j.carbpol.2013.01.013
Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery.
Zheng Pan (2013)
10.1533/9781782422662.32
Natural polymer biomaterials: advanced applications
Elena P. Ivanova (2014)
10.1016/B978-0-12-417205-0.00028-6
Chapter 28 – Designing Prodrugs and Bioprecursors
Yong Mi Choi-Sledeski (2015)
10.1016/j.addr.2015.03.015
Recent advances on anti-HIV vaginal delivery systems development.
Sophia G. Antimisiaris (2015)
10.1016/j.biopha.2015.12.014
Nanoparticles: Novel vehicles in treatment of Glioblastoma.
Fatemeh Pourgholi (2016)
10.1016/B978-0-323-39408-6.00008-X
Polymers with Nano-Encapsulated Functional Polymers
Marli Luiza Tebaldi (2015)
10.3390/md8041305
Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery Systems
Josias H. Hamman (2010)
10.2147/DDDT.S52809
Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells
Mingrong Cheng (2013)
10.1016/j.jconrel.2012.04.027
Block ionomer complexes of PEG-block-poly(4-vinylbenzylphosphonate) and cationic surfactants as highly stable, pH responsive drug delivery system.
Masao Kamimura (2012)
10.1208/s12249-010-9504-y
The Effect of Chitosan as Internal or External Coating on the 5-ASA Release from Calcium Alginate Microparticles
Cristian R. Tapia (2010)
10.1080/15583724.2013.828751
Effect of Physicochemical Properties of Biodegradable Polymers on Nano Drug Delivery
Sonam (2013)
10.1016/j.ijpharm.2018.11.064
Pluronics: Intelligent building units for targeted cancer therapy and molecular imaging.
Nisar Ul Khaliq (2019)
10.1016/j.smaim.2020.04.001
Nanoparticle-based drug delivery systems for cancer therapy
Yu Dang (2020)
Preparation, development and evaluation of novel drug delivery systems for colon targeting
Carla Mura (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar